Montelukastum Unimark (Montelukast Sodium)

Montelukast Sodium works by selectively blocking the cysteinyl leukotriene receptor CysLT1. This prevents leukotriene D4 and related mediators from binding, which in turn reduces bronchial smooth‑muscle contraction, mucus production, vascular leakage, and eosinophil recruitment, leading to decreased airway inflammation and hyper‑responsiveness.

The exact dose of Montelukastum Unimark is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of disease, and clinical response. Standard dosing guidelines exist for different indications, but the prescriber tailors the regimen to each individual’s needs.

Safety data for montelukast in pregnancy are limited, and the drug should only be used if the potential benefit outweighs any possible risk to the fetus. Montelukast is excreted in breast milk; therefore, breastfeeding mothers should discuss the risk‑benefit profile with their physician before continuing therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Montelukastum Unimark. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or other leukotriene blockers such as zafirlukast. Compared with inhaled steroids, montelukast provides a convenient once‑daily tablet but may be less potent for severe asthma; however, it is useful for patients who cannot tolerate inhaled therapy or need additional control.

Montelukastum Unimark should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture and direct sunlight, and avoid storing them in bathrooms or other humid environments to maintain product stability.

The medication is supplied as oral tablets that are swallowed whole with a glass of water. It is usually taken once daily, with or without food, as directed by the prescriber. Patients should not crush, chew, or split the tablets unless specifically instructed.

Serious adverse events, although rare, include severe allergic reactions such as rash, urticaria or angioedema, neuropsychiatric effects like agitation, depression or suicidal thoughts, and liver injury manifested by elevated enzymes or hepatitis. Any of these symptoms should prompt immediate medical evaluation.

Montelukastum Unimark is contraindicated in individuals with a known hypersensitivity to montelukast sodium or any of the tablet’s inactive ingredients. Caution is also advised for patients with uncontrolled asthma who rely on rescue inhalers, as the drug does not replace acute bronchodilator therapy.